NEW YORK, July 24, 2020 /PRNewswire/ --
If you own shares in any of the companies
listed above and
would like to discuss our investigations or have any questions
concerning
this notice or your rights or interests, please contact:
Joshua Rubin,
Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
GAIN Capital Holdings, Inc. (NYSE: GCAP)
WeissLaw LLP is investigating possible breaches of fiduciary
duty and other violations of law by the board of directors of
GAIN Capital Holdings, Inc. (NYSE: GCAP) in connection with
the proposed acquisition of the company by INTL FCStone Inc.
("INTL"). Under the terms of the acquisition agreement, GCAP
shareholders will receive a mere $6.00 per share in cash for each share of GCAP
common stock that they own. The deal is expected to close
during the 3rd quarter of 2020. WeissLaw is
concerned that the merger consideration does not fully value the
company given GCAP's robust performance over the last two fiscal
quarters, and that stockholders did not have all information
necessary to properly evaluate the deal. If you own GCAP
shares and wish to discuss this investigation or your rights,
please call us at one of the numbers listed above or visit our
website:
https://weisslawllp.com/gain-capital-holdings-inc/
MYOS RENS Technology Inc. (NASDAQ: MYOS)
WeissLaw LLP is investigating possible breaches of fiduciary
duty and other violations of law by the board of directors of
MYOS RENS Technology Inc. (NASDAQ: MYOS) in connection with
the proposed merger of the company with privately-held
pharmaceutical company MedAvail, Inc. ("MedAvail"). Under the
terms of the agreement, all of the assets and liabilities of MYOS
(with exception to certain excluded assets) will be contributed to
a subsidiary of MYOS, and shares of that subsidiary will then be
distributed as a dividend to MYOS shareholders immediately
following the closing of the merger. Ultimately, following
the closing of the deal, MYOS shareholders will own only 3.5% of
the new combined company, with MedAvail's security holders and new
investors owning the remaining 96.5% of the new entity. If
you own MYOS shares and wish to discuss this investigation or your
rights, please call us at one of the numbers listed above or visit
our website:
https://weisslawllp.com/myos-rens-technology-inc/
View original content to download
multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-gcap-and-myos-shareholders-about-its-ongoing-investigations-301099688.html
SOURCE WeissLaw LLP